Herborium
to Introduce Product Line Extension
Establishing
Global Partnerships to Expand Distribution Channels
Fort
Lee, N.J., March 12, 2015 - Herborium® Group, Inc. (OTC Pink: HBRM),
www.Herborium.com, a Botanical
Therapeutics®
Company and provider of unique, all botanical medicines (Botanical
Therapeutics®), will deploy new partnerships to develop a product
line extension and tap into new profitable markets for its unique,
all herbal acne treatment, AcnEase®.
The new topical, all natural product is to be introduced in 2015 and
is a highly desirable addition to AcnEase
Skin Management System®
In addition to meeting customers demand this new, complementary acne
product will support a further exponential growth of the brand and
add to the Company’s bottom line as it benefits from AcnEase®
brand recognition, customer base and existing sales infrastructure.
In
addition, the new global and domestic partnerships that are developed
around the product extension include co-marketing arrangements,
allowing AcnEase®
branded products to enter new, large markets including those in Asia.
AcnEase®,
www.acnease.com, that is differentiated by its clinically validated
efficacy and unprecedented safety profile, has up to 96% success rate
in treating acne. The product targets over 750 million acne sufferers
in the United States and Canada, over 80 million people with acne in
Europe, and now 200 million acne sufferers in Asia. 75% of all people
will have acne at in the certain times of their lives
AcnEase
is especially effective in hard treatable cases of adult hormonal
acne in women and men that is becoming more prevailing... Average age
of acne sufferer in the US has increased from 21.5 to 26.5 in the
last decade. After a withdrawal of Accutane (Roche Pharmaceuticals)
from the market due to safety concerns and Class Action Suite, this
dramatically growing and health conscious market was left without an
effective treatment. AcnEase®
is an all-natural and highly effective and safe treatment for adult
and teen acne that is gaining enthusiastic reviews from users. The
total global market for acne treatment is over $4 billion, with the
spending on skin conditions growing at a rate of over 11 percent per
year. Due to environmental conditions and social demand, more and
more individuals seek specialty treatment of acne and related skin
conditions.
“We
are very excited about the prospect of our product line extension
and, new global and domestic partners joining us in building the
AcnEase®
brand throughout the world. This is a large step forwards to continue
the exponential growth of Herborium as a global company, to provide
valuable Botanical
Therapeutics®
to an increasing number of consumers and distributors, and to
increase shareholders value” commented Dr. Agnes P. Olszewski, CEO
and Chairwoman of Herborium. About Herborium Group, Inc.
Herborium
Group, Inc., a botanical therapeutics® company that develops,
license and markets proprietary, botanical based medicinal products
to consumers and healthcare professionals. The Company business model
focuses on emerging market opportunities spearheaded by the growth of
a new market sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a proactive
regulatory strategy based on the FDA Guidance for Industry: Botanical
Drug Products (FDA Guidance 2004) to
establish and maintain a differential advantage. Herborium has
secured a pipeline of botanical ingredients based products in the
areas of dermatological needs, wellness and energy, prostate health,
women’s health and selected sexual disorders resulting from
cardiovascular disease, use of anti-depressants, diabetes, surgical
procedures, and other problems. Herborium Group sells its products in
the United States, the United Kingdom, and continental Europe through
a network of distributors, specialty retailers, and e-commerce. For
more information, please visit www.herborium.com, and
www.acnease.com.
Safe
Harbor Statement: This release contains forward-looking statements
with respect to the results of operations and business of Herborium
Group, Inc., which involves risks and uncertainties. The Company's
actual future results could materially differ from those discussed.
The Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of 1995.
Contact
Information:
Herborium
Group, Inc. Email: InvestorsRelations@Herborium.com
www.DailyStockDeals.com WWW.OTCKING.ocm
No comments:
Post a Comment